Mark Sheptoff Financial Planning, LLC Sanofi Transaction History

Mark Sheptoff Financial Planning, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $19,788 - $21,508	-400 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$42.91 - $52.5 $611,467 - $748,125	-14,250 Reduced 97.27%	400 $20,000
Q1 2020 May 07, 2020	BUY	$38.02 - $51.66 $556,993 - $756,819	14,650 New	14,650 $640,000
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $6,000 - $6,726	-150 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$37.63 - $41.22 $54,563 - $59,769	-1,450 Reduced 90.63%	150 $6,000
Q1 2018 May 08, 2018	SELL	$38.98 - $45.76 $7,795 - $9,152	-200 Reduced 11.11%	1,600 $64,000
Q3 2017 Nov 09, 2017	BUY	$47.04 - $50.34 $84,672 - $90,612	1,800	1,800 $90,000

800

266M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.